

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.74103976 |
| 2 | leukocyte aggregation (GO:0070486) | 5.66969657 |
| 3 | response to peptidoglycan (GO:0032494) | 5.66460047 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.24285960 |
| 5 | respiratory burst (GO:0045730) | 5.13610708 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.93898636 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.93898636 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.93898636 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.93898636 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.93898636 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.93898636 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.88870072 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.72149510 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.64136450 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.57284958 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.34583393 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34583393 |
| 18 | neutrophil mediated immunity (GO:0002446) | 4.27291024 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.27242427 |
| 20 | neutrophil activation (GO:0042119) | 4.23170513 |
| 21 | granulocyte activation (GO:0036230) | 4.07398617 |
| 22 | cellular extravasation (GO:0045123) | 3.95526001 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 3.93572167 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.92502091 |
| 25 | regulation of B cell differentiation (GO:0045577) | 3.84778601 |
| 26 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.84393523 |
| 27 | positive regulation of antigen processing and presentation (GO:0002579) | 3.83130685 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82874318 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.82546750 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 3.76745209 |
| 31 | cellular response to zinc ion (GO:0071294) | 3.74549547 |
| 32 | detection of biotic stimulus (GO:0009595) | 3.74031184 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.69250052 |
| 34 | response to fungus (GO:0009620) | 3.64810644 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.63689258 |
| 36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.63069861 |
| 37 | B cell mediated immunity (GO:0019724) | 3.62840763 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.61657511 |
| 39 | response to host immune response (GO:0052572) | 3.61086491 |
| 40 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.61086491 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 3.60132844 |
| 42 | response to interleukin-15 (GO:0070672) | 3.59750008 |
| 43 | microglial cell activation (GO:0001774) | 3.58798694 |
| 44 | reactive oxygen species biosynthetic process (GO:1903409) | 3.57161480 |
| 45 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.55712839 |
| 46 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.54825265 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.52028718 |
| 48 | negative regulation of cell killing (GO:0031342) | 3.50348103 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.50348103 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.47048076 |
| 51 | macrophage activation (GO:0042116) | 3.46084881 |
| 52 | leukocyte mediated cytotoxicity (GO:0001909) | 3.45417077 |
| 53 | defense response to protozoan (GO:0042832) | 3.45294301 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 3.44977164 |
| 55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.44087764 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 3.43474137 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.39269450 |
| 58 | regulation of mast cell activation (GO:0033003) | 3.38845031 |
| 59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.38072570 |
| 60 | negative regulation of phagocytosis (GO:0050765) | 3.37672955 |
| 61 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.36271714 |
| 62 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.33705463 |
| 63 | superoxide anion generation (GO:0042554) | 3.32283072 |
| 64 | regulation of interferon-alpha production (GO:0032647) | 3.31440161 |
| 65 | myeloid leukocyte mediated immunity (GO:0002444) | 3.28950541 |
| 66 | response to host (GO:0075136) | 3.28551162 |
| 67 | response to host defenses (GO:0052200) | 3.28551162 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28551162 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.27704439 |
| 70 | cellular response to interleukin-15 (GO:0071350) | 3.26813829 |
| 71 | positive regulation of mast cell degranulation (GO:0043306) | 3.26643280 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.26643280 |
| 73 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26473816 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 3.26473243 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24599211 |
| 76 | negative regulation of T cell mediated immunity (GO:0002710) | 3.23409944 |
| 77 | germinal center formation (GO:0002467) | 3.23026179 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19474335 |
| 79 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.19312671 |
| 80 | regulation of growth of symbiont in host (GO:0044126) | 3.19312671 |
| 81 | negative regulation of growth of symbiont in host (GO:0044130) | 3.19312671 |
| 82 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.19312671 |
| 83 | response to protozoan (GO:0001562) | 3.18541061 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 3.17968197 |
| 85 | leukocyte cell-cell adhesion (GO:0007159) | 3.16962627 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16433404 |
| 87 | regulation of T cell tolerance induction (GO:0002664) | 3.15136800 |
| 88 | mast cell activation (GO:0045576) | 3.14634910 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14298735 |
| 90 | neutrophil chemotaxis (GO:0030593) | 3.13950315 |
| 91 | defense response to fungus (GO:0050832) | 3.12724683 |
| 92 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.12597191 |
| 93 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.12597191 |
| 94 | regulation of gamma-delta T cell activation (GO:0046643) | 3.11751646 |
| 95 | detection of other organism (GO:0098543) | 3.10281946 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.10250187 |
| 97 | regulation of tolerance induction (GO:0002643) | 3.09939923 |
| 98 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.09575050 |
| 99 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.08611879 |
| 100 | T cell migration (GO:0072678) | 3.08281104 |
| 101 | regulation of regulated secretory pathway (GO:1903305) | 3.07993113 |
| 102 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07300414 |
| 103 | neutrophil migration (GO:1990266) | 3.04937473 |
| 104 | positive thymic T cell selection (GO:0045059) | 3.04634837 |
| 105 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.01081937 |
| 106 | natural killer cell mediated immunity (GO:0002228) | 3.01081937 |
| 107 | type I interferon signaling pathway (GO:0060337) | 2.99689769 |
| 108 | cellular response to type I interferon (GO:0071357) | 2.99689769 |
| 109 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.99680281 |
| 110 | response to type I interferon (GO:0034340) | 2.98694743 |
| 111 | negative regulation of interleukin-6 production (GO:0032715) | 2.98114577 |
| 112 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.97796429 |
| 113 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96846615 |
| 114 | myeloid dendritic cell activation (GO:0001773) | 2.96335145 |
| 115 | leukocyte degranulation (GO:0043299) | 2.96057712 |
| 116 | actin nucleation (GO:0045010) | 2.95670177 |
| 117 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.95296515 |
| 118 | negative regulation of innate immune response (GO:0045824) | 2.92664261 |
| 119 | regulation of leukocyte degranulation (GO:0043300) | 2.90141216 |
| 120 | detection of bacterium (GO:0016045) | 2.88696404 |
| 121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88457021 |
| 122 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.84908728 |
| 123 | myeloid leukocyte activation (GO:0002274) | 2.84430368 |
| 124 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.82944951 |
| 125 | negative thymic T cell selection (GO:0045060) | 2.82872433 |
| 126 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80046917 |
| 127 | myeloid dendritic cell differentiation (GO:0043011) | 2.80046280 |
| 128 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.80029834 |
| 129 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79610363 |
| 130 | regulation of chemokine biosynthetic process (GO:0045073) | 2.78911943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.73665126 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.17781069 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.76314786 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.88709088 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.83437589 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72722138 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.68767508 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.52341078 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.44960822 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.37341045 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26527262 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.25363381 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.12749694 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.96086609 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.94116084 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.69679110 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.63531890 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61888784 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56810537 |
| 20 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52801769 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50921108 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.48726345 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.39033151 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.35579116 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27950135 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.22529963 |
| 27 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.21144259 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.16967747 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 2.14918229 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.14696021 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04360361 |
| 32 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03573899 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02777891 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97687396 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.89272350 |
| 36 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.84886295 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84284435 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84200688 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81465054 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74497793 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73270209 |
| 42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63258505 |
| 43 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62413634 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57177134 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56361449 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.56163039 |
| 47 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55515562 |
| 48 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52907076 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47842301 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.46650581 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45407907 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43165511 |
| 53 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39598871 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.34855435 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33540275 |
| 56 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32043540 |
| 57 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31585298 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30118879 |
| 59 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29720026 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29139483 |
| 61 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26517641 |
| 62 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25177566 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21148280 |
| 64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20549560 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20104331 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18850690 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18769024 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18226922 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17789799 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16314884 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15687079 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15029807 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13400190 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12085984 |
| 75 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12072287 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11520530 |
| 77 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09935519 |
| 78 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08809562 |
| 79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08465453 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06519621 |
| 81 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04350560 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04163975 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03964551 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03414810 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02639031 |
| 86 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00863284 |
| 87 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00108389 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99974718 |
| 89 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99809816 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99613695 |
| 91 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98571364 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98545141 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97637121 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97211672 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95268515 |
| 96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92922198 |
| 97 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92158753 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91031225 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90659083 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89393672 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86614465 |
| 102 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.84190189 |
| 103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83522751 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80055327 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78567574 |
| 106 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.71302230 |
| 107 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.71035544 |
| 108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70080479 |
| 109 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.69804989 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69734311 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69441421 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68433593 |
| 113 | P300_27268052_Chip-Seq_Bcells_Human | 0.67963701 |
| 114 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.66648933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.58932696 |
| 2 | MP0003436_decreased_susceptibility_to | 3.87591115 |
| 3 | MP0003303_peritoneal_inflammation | 3.76840903 |
| 4 | MP0009785_altered_susceptibility_to | 3.73379844 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.24861953 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.18748578 |
| 7 | MP0000685_abnormal_immune_system | 3.07810635 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.06202874 |
| 9 | MP0005387_immune_system_phenotype | 3.00935009 |
| 10 | MP0001790_abnormal_immune_system | 3.00935009 |
| 11 | * MP0005025_abnormal_response_to | 3.00679075 |
| 12 | MP0005671_abnormal_response_to | 3.00020637 |
| 13 | MP0001800_abnormal_humoral_immune | 2.98870411 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.88833255 |
| 15 | MP0002723_abnormal_immune_serum | 2.67740558 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.61787373 |
| 17 | * MP0001819_abnormal_immune_cell | 2.60686373 |
| 18 | MP0006082_CNS_inflammation | 2.42280155 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.36150190 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.31818801 |
| 21 | MP0002405_respiratory_system_inflammati | 2.30780942 |
| 22 | MP0003724_increased_susceptibility_to | 2.25101514 |
| 23 | MP0001853_heart_inflammation | 2.09871167 |
| 24 | MP0002398_abnormal_bone_marrow | 2.09364896 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.04409710 |
| 26 | MP0000716_abnormal_immune_system | 2.03928798 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.99670397 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.98048278 |
| 29 | MP0004510_myositis | 1.95240129 |
| 30 | MP0009278_abnormal_bone_marrow | 1.93782846 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.84342264 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.82866693 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.81509014 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.80622467 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.78259530 |
| 36 | MP0004947_skin_inflammation | 1.76972524 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.72644039 |
| 38 | MP0002429_abnormal_blood_cell | 1.70821498 |
| 39 | MP0002722_abnormal_immune_system | 1.69811592 |
| 40 | MP0002132_abnormal_respiratory_system | 1.65633656 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.62909814 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.62909814 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.62727999 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.61869951 |
| 45 | MP0000343_altered_response_to | 1.58260034 |
| 46 | MP0000858_altered_metastatic_potential | 1.57046729 |
| 47 | MP0002006_tumorigenesis | 1.56799978 |
| 48 | MP0003448_altered_tumor_morphology | 1.55418416 |
| 49 | MP0008469_abnormal_protein_level | 1.55345390 |
| 50 | MP0005310_abnormal_salivary_gland | 1.53313564 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.45860379 |
| 52 | MP0009764_decreased_sensitivity_to | 1.43445319 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.42473030 |
| 54 | MP0001873_stomach_inflammation | 1.38897018 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.35131766 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.33366597 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.31574901 |
| 58 | MP0005451_abnormal_body_composition | 1.28869689 |
| 59 | MP0002933_joint_inflammation | 1.28734748 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.28509552 |
| 61 | MP0003075_altered_response_to | 1.21351730 |
| 62 | MP0010307_abnormal_tumor_latency | 1.15684189 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.14074693 |
| 64 | MP0000490_abnormal_crypts_of | 1.12880699 |
| 65 | MP0001851_eye_inflammation | 1.05427544 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.03415303 |
| 67 | MP0003866_abnormal_defecation | 1.00174384 |
| 68 | MP0009840_abnormal_foam_cell | 0.98779720 |
| 69 | MP0005166_decreased_susceptibility_to | 0.97138404 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.95679016 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.95597516 |
| 72 | MP0000604_amyloidosis | 0.94840232 |
| 73 | MP0008004_abnormal_stomach_pH | 0.91872083 |
| 74 | MP0005076_abnormal_cell_differentiation | 0.91598460 |
| 75 | MP0009763_increased_sensitivity_to | 0.90439841 |
| 76 | MP0004381_abnormal_hair_follicle | 0.89784084 |
| 77 | MP0003828_pulmonary_edema | 0.87787424 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.86891789 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.86640013 |
| 80 | MP0005390_skeleton_phenotype | 0.84028339 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.79330899 |
| 82 | MP0003186_abnormal_redox_activity | 0.74085292 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.73608704 |
| 84 | MP0001663_abnormal_digestive_system | 0.71016941 |
| 85 | MP0008260_abnormal_autophagy | 0.70771812 |
| 86 | MP0000249_abnormal_blood_vessel | 0.68655819 |
| 87 | MP0005164_abnormal_response_to | 0.68439854 |
| 88 | MP0003693_abnormal_embryo_hatching | 0.67521998 |
| 89 | MP0003045_fibrosis | 0.67150687 |
| 90 | MP0005023_abnormal_wound_healing | 0.67073023 |
| 91 | MP0000371_diluted_coat_color | 0.65775603 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.65703578 |
| 93 | MP0003795_abnormal_bone_structure | 0.62921216 |
| 94 | MP0008057_abnormal_DNA_replication | 0.62856603 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.62713645 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.60379393 |
| 97 | MP0008874_decreased_physiological_sensi | 0.58586861 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.56771053 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.56600677 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.55733595 |
| 101 | MP0004883_abnormal_blood_vessel | 0.55668626 |
| 102 | MP0008873_increased_physiological_sensi | 0.54931191 |
| 103 | MP0003329_amyloid_beta_deposits | 0.53749430 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.53565957 |
| 105 | MP0000920_abnormal_myelination | 0.51814226 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.51057018 |
| 107 | MP0000313_abnormal_cell_death | 0.50982276 |
| 108 | MP0000609_abnormal_liver_physiology | 0.50521583 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.50044378 |
| 110 | MP0003077_abnormal_cell_cycle | 0.48764332 |
| 111 | MP0003690_abnormal_glial_cell | 0.47471069 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.47224587 |
| 113 | MP0005083_abnormal_biliary_tract | 0.46899014 |
| 114 | MP0005381_digestive/alimentary_phenotyp | 0.46126755 |
| 115 | MP0006054_spinal_hemorrhage | 0.44732283 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.44552807 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.42523969 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.41904977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Recurrent abscess formation (HP:0002722) | 7.32358331 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.19854671 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.95188184 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.93070759 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.02723821 |
| 6 | Recurrent skin infections (HP:0001581) | 4.54585889 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.54290228 |
| 8 | * Mediastinal lymphadenopathy (HP:0100721) | 4.46315281 |
| 9 | Myositis (HP:0100614) | 4.45170968 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.41473119 |
| 11 | * Chronic obstructive pulmonary disease (HP:0006510) | 4.20217244 |
| 12 | * Obstructive lung disease (HP:0006536) | 4.20217244 |
| 13 | Cellulitis (HP:0100658) | 3.99578407 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.78762737 |
| 15 | Recurrent viral infections (HP:0004429) | 3.72858916 |
| 16 | * Gingivitis (HP:0000230) | 3.64055113 |
| 17 | IgM deficiency (HP:0002850) | 3.57153917 |
| 18 | * Meningitis (HP:0001287) | 3.56565569 |
| 19 | Orchitis (HP:0100796) | 3.52205180 |
| 20 | Vasculitis (HP:0002633) | 3.50776687 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.48970253 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.47736487 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.47736487 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.42848599 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.36878798 |
| 26 | Optic neuritis (HP:0100653) | 3.36878798 |
| 27 | Prolonged bleeding time (HP:0003010) | 3.35315864 |
| 28 | Pustule (HP:0200039) | 3.35189502 |
| 29 | Chronic otitis media (HP:0000389) | 3.32735553 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.23362874 |
| 31 | Recurrent bronchitis (HP:0002837) | 3.17667363 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.16146124 |
| 33 | Hypochromic microcytic anemia (HP:0004840) | 3.10713596 |
| 34 | Periodontitis (HP:0000704) | 3.05223695 |
| 35 | Recurrent pneumonia (HP:0006532) | 3.01849391 |
| 36 | Agammaglobulinemia (HP:0004432) | 2.97640425 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94488752 |
| 38 | Osteomyelitis (HP:0002754) | 2.93094668 |
| 39 | Hypochromic anemia (HP:0001931) | 2.91545906 |
| 40 | Pulmonary infiltrates (HP:0002113) | 2.88247976 |
| 41 | Petechiae (HP:0000967) | 2.88202411 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.85910559 |
| 43 | * Urticaria (HP:0001025) | 2.79823191 |
| 44 | Leukocytosis (HP:0001974) | 2.79216536 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.77935805 |
| 46 | Episodic fever (HP:0001954) | 2.75960624 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.74370123 |
| 48 | Thrombocytosis (HP:0001894) | 2.74234864 |
| 49 | Colitis (HP:0002583) | 2.71884411 |
| 50 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.70709819 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.69210804 |
| 52 | Recurrent lower respiratory tract infections (HP:0002783) | 2.67019195 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.64573203 |
| 54 | Purpura (HP:0000979) | 2.64170027 |
| 55 | Amyloidosis (HP:0011034) | 2.63970708 |
| 56 | Lymphopenia (HP:0001888) | 2.63922550 |
| 57 | Loss of speech (HP:0002371) | 2.63524688 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62758459 |
| 59 | Pulmonary embolism (HP:0002204) | 2.57436323 |
| 60 | Abnormality of T cells (HP:0002843) | 2.56266744 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.56257017 |
| 62 | Thyroiditis (HP:0100646) | 2.55167962 |
| 63 | Basal ganglia calcification (HP:0002135) | 2.52714161 |
| 64 | Increased serum ferritin (HP:0003281) | 2.51339018 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 2.50435222 |
| 66 | Anorexia (HP:0002039) | 2.47551007 |
| 67 | * Stomatitis (HP:0010280) | 2.46890610 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.46085984 |
| 69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.46085984 |
| 70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.46085984 |
| 71 | Agnosia (HP:0010524) | 2.45167495 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.43655881 |
| 73 | Disinhibition (HP:0000734) | 2.43438314 |
| 74 | Hemoptysis (HP:0002105) | 2.42563870 |
| 75 | Eosinophilia (HP:0001880) | 2.41756740 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.34300947 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.33898588 |
| 78 | Microcytic anemia (HP:0001935) | 2.32114794 |
| 79 | T lymphocytopenia (HP:0005403) | 2.31717082 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.30637176 |
| 81 | Arterial thrombosis (HP:0004420) | 2.30109082 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.28698262 |
| 83 | Nasal polyposis (HP:0100582) | 2.28468945 |
| 84 | Chest pain (HP:0100749) | 2.28040802 |
| 85 | * Sepsis (HP:0100806) | 2.26696635 |
| 86 | Panhypogammaglobulinemia (HP:0003139) | 2.26094982 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.24727195 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24727195 |
| 89 | Glomerulonephritis (HP:0000099) | 2.23930337 |
| 90 | * Skin ulcer (HP:0200042) | 2.23078811 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.22914189 |
| 92 | Increased IgM level (HP:0003496) | 2.22523598 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.22321666 |
| 94 | Keratoconjunctivitis (HP:0001096) | 2.21992542 |
| 95 | Granulocytopenia (HP:0001913) | 2.20815325 |
| 96 | Axonal loss (HP:0003447) | 2.20403669 |
| 97 | Abnormality of eosinophils (HP:0001879) | 2.20225257 |
| 98 | Gingival bleeding (HP:0000225) | 2.20216493 |
| 99 | Gangrene (HP:0100758) | 2.19228800 |
| 100 | Increased IgE level (HP:0003212) | 2.17340534 |
| 101 | Encephalitis (HP:0002383) | 2.16319009 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 2.15876352 |
| 103 | Combined immunodeficiency (HP:0005387) | 2.15778224 |
| 104 | Restrictive lung disease (HP:0002091) | 2.15220777 |
| 105 | Epistaxis (HP:0000421) | 2.14718844 |
| 106 | Peritonitis (HP:0002586) | 2.13216305 |
| 107 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.12071617 |
| 108 | IgG deficiency (HP:0004315) | 2.10452019 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09873446 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09873446 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09873446 |
| 112 | Severe combined immunodeficiency (HP:0004430) | 2.07776027 |
| 113 | Autoimmune hemolytic anemia (HP:0001890) | 2.07636510 |
| 114 | IgA deficiency (HP:0002720) | 2.05762450 |
| 115 | Glomerulopathy (HP:0100820) | 2.05559942 |
| 116 | Abnormality of the peritoneum (HP:0002585) | 2.05044286 |
| 117 | Hematochezia (HP:0002573) | 2.02927350 |
| 118 | Chronic diarrhea (HP:0002028) | 2.02900295 |
| 119 | Polyneuropathy (HP:0001271) | 2.01668808 |
| 120 | Abnormality of the nasal mucosa (HP:0000433) | 2.01488703 |
| 121 | Premature loss of primary teeth (HP:0006323) | 2.00547547 |
| 122 | Vertigo (HP:0002321) | 1.97416180 |
| 123 | Skin rash (HP:0000988) | 1.97413053 |
| 124 | Acute hepatic failure (HP:0006554) | 1.93564090 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92723485 |
| 126 | Acne (HP:0001061) | 1.88668770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.34077137 |
| 2 | BLK | 4.13095321 |
| 3 | IRAK4 | 3.87862006 |
| 4 | RIPK4 | 3.34553279 |
| 5 | MAP3K14 | 3.03015895 |
| 6 | TYK2 | 2.63795300 |
| 7 | TBK1 | 2.60741894 |
| 8 | KIT | 2.47077391 |
| 9 | TXK | 2.43893485 |
| 10 | IRAK3 | 2.42054944 |
| 11 | BTK | 2.23833684 |
| 12 | IKBKE | 2.19688897 |
| 13 | PRPF4B | 2.15274403 |
| 14 | JAK3 | 2.11376274 |
| 15 | CSF1R | 2.07832416 |
| 16 | ERN1 | 2.01678924 |
| 17 | ZAP70 | 1.99687625 |
| 18 | SYK | 1.96676648 |
| 19 | FES | 1.81211227 |
| 20 | CSK | 1.80377193 |
| 21 | IKBKB | 1.79400771 |
| 22 | TEC | 1.77360743 |
| 23 | STK10 | 1.70872347 |
| 24 | HCK | 1.63148196 |
| 25 | MAP2K3 | 1.53254467 |
| 26 | JAK1 | 1.51584436 |
| 27 | TAOK3 | 1.49553232 |
| 28 | GRK6 | 1.49104263 |
| 29 | LYN | 1.45941296 |
| 30 | NME2 | 1.41167034 |
| 31 | MAP3K10 | 1.40303180 |
| 32 | LCK | 1.35331564 |
| 33 | MAP3K13 | 1.33327739 |
| 34 | CLK1 | 1.33323565 |
| 35 | TESK2 | 1.30697166 |
| 36 | MAP3K1 | 1.23222689 |
| 37 | EPHB1 | 1.23100255 |
| 38 | ITK | 1.21432683 |
| 39 | FGR | 1.18095523 |
| 40 | PIM1 | 1.14797326 |
| 41 | LRRK2 | 1.10896870 |
| 42 | PIM2 | 1.06672557 |
| 43 | RPS6KA4 | 1.05010979 |
| 44 | TRPM7 | 1.02381343 |
| 45 | KDR | 0.98757058 |
| 46 | MAP3K12 | 0.96880694 |
| 47 | TGFBR2 | 0.94484579 |
| 48 | NEK9 | 0.91401174 |
| 49 | KSR2 | 0.89852251 |
| 50 | SMG1 | 0.89518207 |
| 51 | CHUK | 0.89383870 |
| 52 | MATK | 0.88795611 |
| 53 | JAK2 | 0.87475253 |
| 54 | MAP3K11 | 0.83660726 |
| 55 | MARK2 | 0.82569300 |
| 56 | IRAK2 | 0.81172188 |
| 57 | STK4 | 0.79785411 |
| 58 | MARK3 | 0.79689873 |
| 59 | IRAK1 | 0.78883325 |
| 60 | TESK1 | 0.76733289 |
| 61 | PRKD2 | 0.76548314 |
| 62 | SIK2 | 0.74395308 |
| 63 | CDK19 | 0.70059530 |
| 64 | PBK | 0.69962423 |
| 65 | MAP3K6 | 0.68560320 |
| 66 | EIF2AK3 | 0.68311866 |
| 67 | PDPK1 | 0.67155197 |
| 68 | FLT3 | 0.65998249 |
| 69 | MAPK12 | 0.63263923 |
| 70 | ABL1 | 0.58017155 |
| 71 | PKN2 | 0.57827234 |
| 72 | YES1 | 0.57173930 |
| 73 | TRIB3 | 0.56994292 |
| 74 | MAP2K6 | 0.56022403 |
| 75 | * PRKCD | 0.55886145 |
| 76 | MST4 | 0.54538325 |
| 77 | PAK4 | 0.53847922 |
| 78 | TTN | 0.53719346 |
| 79 | NEK2 | 0.52569981 |
| 80 | RPS6KA6 | 0.52272603 |
| 81 | EIF2AK2 | 0.51284742 |
| 82 | TNK2 | 0.50786347 |
| 83 | CDC42BPA | 0.50106551 |
| 84 | EEF2K | 0.50069408 |
| 85 | MAPK4 | 0.48730281 |
| 86 | MAP3K7 | 0.48165240 |
| 87 | CAMKK2 | 0.47781499 |
| 88 | PIK3CG | 0.47760911 |
| 89 | HIPK2 | 0.47347503 |
| 90 | MAP3K3 | 0.46928566 |
| 91 | DAPK2 | 0.46693171 |
| 92 | MAPKAPK2 | 0.46647773 |
| 93 | EGFR | 0.46221311 |
| 94 | PRKCQ | 0.46071729 |
| 95 | CDK4 | 0.46040887 |
| 96 | MAP2K4 | 0.45787411 |
| 97 | SCYL2 | 0.44416408 |
| 98 | MAP3K8 | 0.43336555 |
| 99 | RPS6KL1 | 0.42652996 |
| 100 | RPS6KC1 | 0.42652996 |
| 101 | FGFR3 | 0.40510494 |
| 102 | FGFR4 | 0.40441416 |
| 103 | STK11 | 0.40322096 |
| 104 | FYN | 0.40151239 |
| 105 | MAPK7 | 0.38939740 |
| 106 | GRK7 | 0.38220162 |
| 107 | DYRK1B | 0.38123778 |
| 108 | RAF1 | 0.36587368 |
| 109 | PTK6 | 0.35630787 |
| 110 | ABL2 | 0.35316644 |
| 111 | PDK1 | 0.35218880 |
| 112 | SIK3 | 0.35123697 |
| 113 | CAMKK1 | 0.31483924 |
| 114 | MAP3K5 | 0.31286709 |
| 115 | ALK | 0.31269739 |
| 116 | EIF2AK1 | 0.30140649 |
| 117 | TAOK1 | 0.28729053 |
| 118 | MAP2K2 | 0.27978402 |
| 119 | ERBB3 | 0.27332468 |
| 120 | RET | 0.27329205 |
| 121 | PTK2B | 0.26700242 |
| 122 | CDK6 | 0.26536623 |
| 123 | PRKG2 | 0.26304207 |
| 124 | MAPK11 | 0.24707621 |
| 125 | ACVR1B | 0.24659022 |
| 126 | STK24 | 0.24335796 |
| 127 | TAOK2 | 0.23596889 |
| 128 | BMPR2 | 0.23516289 |
| 129 | SIK1 | 0.21313105 |
| 130 | RPS6KA1 | 0.20889440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.32525061 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.89750687 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53569798 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.50139496 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.48369281 |
| 6 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45471391 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.32100495 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.30124778 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.22147303 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.13205568 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.10876693 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.10574308 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09957048 |
| 14 | Measles_Homo sapiens_hsa05162 | 2.07924842 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07577035 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.00612591 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98738891 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.98299732 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97148047 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.95976190 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91804942 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.87629353 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87354840 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.82751114 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82121067 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.77729732 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67481773 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.56686200 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.53888232 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52550314 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48305585 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47887212 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46870879 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.46649526 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.45729171 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43787640 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42545984 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34901598 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30280183 |
| 40 | * Phagosome_Homo sapiens_hsa04145 | 1.29192466 |
| 41 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27710805 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27161212 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24673158 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 1.22627243 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18877810 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18160614 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15374771 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.15180398 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12468295 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07130606 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03980033 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94594714 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93937240 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88556163 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86971711 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.82531792 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.81846419 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80563008 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80315865 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76581840 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75861371 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.75192167 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74970716 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73235359 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70695382 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64211947 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.63996899 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60530875 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58303952 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.57291313 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56370911 |
| 72 | Homologous recombination_Homo sapiens_hsa03440 | 0.53606555 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52256653 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51437553 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50222910 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48855136 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48472719 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48315022 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47632240 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44022150 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42988596 |
| 82 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40493125 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39898314 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38808948 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38078722 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37796561 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37771157 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37413334 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.37121929 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37083943 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36425227 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36280267 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35677729 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34292867 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33815268 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33403621 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32475205 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32316580 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32015857 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.31720221 |
| 101 | Proteasome_Homo sapiens_hsa03050 | 0.31345023 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31308123 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31182694 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30578100 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28491946 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28107878 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.27339412 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26993810 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26214242 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23576094 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22945314 |
| 112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22222182 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21743581 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20470292 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20322960 |
| 116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.19219210 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18437789 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.17693922 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15789402 |

